Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.37 | 2e-14 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.35 | 3e-11 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.29 | 1e-08 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-08 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 6e-07 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |